Optimization

Creatine

Cellular energy buffering and muscle performance, largely untested in dogs.

Nara’s evidence view

Research watchlist

PreliminaryCanine biomarkersLow confidence

The claim we’re evaluating

Routine creatine supplementation in generally healthy dogs improves muscle performance, body composition, cognition, recovery, or healthy-aging outcomes beyond a nutritionally adequate diet.

Nara’s interpretation

Canine creatine research establishes oral bioavailability and measurable changes in circulating or tissue creatine, but it does not establish routine performance, body-composition, cognitive, recovery, or healthy-aging benefit in dogs. Human resistance-training research makes those uses biologically plausible but is not canine efficacy evidence and has itself produced heterogeneous results. Creatine-containing supplementation can also transiently alter measured creatinine in dogs, which matters for laboratory interpretation but is neither proof of kidney injury nor proof of individual renal safety.

Personalized

What this means for your dog.

Loading your dog’s context…

Evidence briefing

What Nara knows now.

A bounded position while the full claim-level dossier is still being completed.

What is known

A 1998 canine study showed that increasing dietary creatine changed plasma and muscle creatine concentrations, establishing biological availability rather than a clinically meaningful outcome. A 2022 study in eight healthy adult Beagles found that a top-dressed combination containing creatine, carnitine, and choline increased postprandial plasma creatine and creatinine; its short duration, small sample, combination formulation, and biomarker focus prevent efficacy conclusions. Human trials in older adults provide direct human evidence that creatine combined with resistance training can improve some strength or lean-mass outcomes, while other trials report little or no additional benefit. The phosphocreatine energy-buffering mechanism is biologically relevant but does not demonstrate a canine outcome.

What is not known

Peer-reviewed canine efficacy evidence for meaningful performance, body-composition, cognitive, recovery, or aging outcomes is extremely sparse. The 1998 dog study primarily addressed creatine concentrations rather than clinical or functional outcomes. The 2022 dog study used only eight Beagles, short feeding periods, and a creatine-carnitine-choline combination, so effects cannot be attributed solely to creatine beyond its measured concentration changes. Available canine studies do not establish long-term safety across kidney disease, medication exposure, aging, or other clinical contexts.

Current position

Canine creatine research establishes oral bioavailability and measurable changes in circulating or tissue creatine, but it does not establish routine performance, body-composition, cognitive, recovery, or healthy-aging benefit in dogs. Human resistance-training research makes those uses biologically plausible but is not canine efficacy evidence and has itself produced heterogeneous results. Creatine-containing supplementation can also transiently alter measured creatinine in dogs, which matters for laboratory interpretation but is neither proof of kidney injury nor proof of individual renal safety.